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Hypertrophy of infected Peyer’s patches arises
from global, interferon-receptor, and CD69-
independent shutdown of lymphocyte egress
O Schulz1, M Ugur1, M Friedrichsen1, K Radulovic2, J-H Niess2,4, S Jalkanen3, A Krueger1 and O Pabst1
Lymphoid organ hypertrophy is a hallmark of localized infection. During the inflammatory response,massive changes in
lymphocyte recirculation and turnover boost lymphoid organ cellularity. Intriguingly, the exact nature of these changes
remains undefined todate.Here,we report that hypertrophyofSalmonella-infectedPeyer’s patches (PPs) ensues froma
global ‘‘shutdown’’ of lymphocyte egress,which traps recirculating lymphocytes in PPs. Surprisingly, infection-induced
lymphocyte sequestration did not require previously proposedmediators of lymphoid organ shutdown including type I
interferon receptor andCD69. In contrast, following T-cell receptor-mediated priming, CD69was essential to selectively
block CD4þ effector T-cell egress. Our findings segregate two distinct lymphocyte sequestration mechanisms, which
differentially rely on intrinsic modulation of lymphocyte egress capacity and inflammation-induced changes in the
lymphoid organ environment.
INTRODUCTION
Lymphocytes continuously enter and exit secondary lymphoid
organs. Local infection and inflammation can drastically change
lymphocyte recirculation, increase lymphoid organ cellularity,
and cause lymphoid organ hypertrophy. Triggers of this process
include type I interferon (IFNa/b),1 tumor necrosis factor
(TNF)-a,2–6 bacterial lipopolysaccharide,6 peptidoglycan,7 com-
plete Freund’s adjuvant,8 interleukin (IL)-6,3 IL-1,6 prostaglandin
E2,9 and complement activation.10 Lymphoid organ hypertrophy
is considered to facilitate encounter of antigen-presenting cells
and antigen-specific naive lymphocytes,4,11,12 thus enabling the
efficient induction of adaptive immune responses.8,13
However, the mechanisms that bring about lymphocyte
accumulation in hypertrophic organs are poorly understood.
Lymph node hypertrophy has been associated with enhanced
recruitment of naive lymphocytes from blood.4–6,8,14,15 In
addition, lymphocyte proliferation is thought to support the
increase in the total lymphocyte numbers.16,17 Finally, lymph
nodes can temporarily ‘‘shut down’’ lymphocyte egress in
response to a variety of stimuli such as antigen, TNF-a, and
IFNa/b.2,3,9,10,18 How changes in lymphocyte entry, proliferation,
and egress integrate to cause lymphoid organ hypertrophy is
unclear.
Lymphocyte egress from secondary lymphoid organs is an
actively regulated process, which requires sphingosine-1-
phosphate receptor 1 (S1PR1) on lymphocytes.19 Studies on
IFNa/b-induced lymphopenia have linked lymphoid organ
shutdown to S1PR1-mediated lymphocyte egress.20,21 Engage-
ment of type I interferon receptor (IFNAR) on lymphocytes
upregulates early activation marker CD69. Through direct
interaction, CD69 causes internalization of cell surface S1PR1,
thus abrogating the egress capability of the lymphocyte.20,22 Via
this IFNAR/CD69/S1PR1 axis, systemically administered
IFNa/b inducers are thought to block lymphocyte egress from
secondary lymphoid organs and cause the observed loss of
lymphocytes from blood and lymph.20 Without direct experi-
mental evidence, the same mechanism has been proposed to
mediate lymphoid organ shutdown during local immune
responses and lymph node hypertrophy.20Many inflammatory
stimuli trigger IFNa/b production and, furthermore, TNF-a or
T-cell receptor (TCR) activation also directly induces CD69
expression.20–24 Thus, the IFNAR/CD69/S1PR1 axis has
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become the paradigm to explain lymphoid organ shutdown
during local immune responses.11,25,26
Intriguingly, lymphocyte egress has not been directly
investigated in the context of localized infection and lymphoid
organ hypertrophy. Efferent lymph - that is, lymph leaving
secondary lymphoid organs - is difficult to access in mice and
only recently, in-situ labeling techniques such as photoconver-
sion have started to be employed tomonitor cell trafficking.27,28
In the context of lymphoid organ hypertrophy, mouse studies
have relied on indirect readouts of egress such as retention of
adoptively transferred cells15 upon L-selectin blockade or
FTY720 pretreatment.8 However, because lymphocyte entry
and exit regulation are closely linked,29 these indirect
approaches do not always appropriately separate both effects.
Owing to these technical limitations, the requirements for
lymphocyte egress from hypertrophic lymphoid organs have
not been directly addressed.
Similarly, it has not been directly investigated to which
degree lymphopenia-inducing substances compromise lym-
phocyte egress on the organ level. CD69-deficient lymphocytes
enter lymph node cortical sinuses more efficiently than CD69-
proficient cells after stimulation with lymphopenia-inducing
polyinosinic–polycytidylic acid (polyI:C).30 However, IFNa/b-
induced lymphopenia has been suggested to rely on mechan-
isms other than lymphocyte sequestration—for example,
increased lymphocyte attachment to vascular endothelium.21,31
Consequently, it is unknown how representative the effects of
polyI:C and other lymphopenia inducers are of the dynamics in
lymphoid organs undergoing immune activation. In fact, only
few studies have actually employed genuine infectionmodels to
study lymph node enlargement14,15,17 and it has not been
shown in a full immune response to localized infection whether
the IFNAR/CD69/S1PR1 axis possesses the capacity tomediate
a general, organ-wide egress shutdown.11,12,24,32
In this study, we use in situ labeling and intestinal lymph
isolation to investigate the cellular dynamics leading to hyper-
trophy of Salmonella-infected intestinal Peyer’s patches (PPs)
and address the molecular requirements for egress from
infected PPs. We report that infected PPs establish a compart-
ment-wide egress blockade that affects all major recirculating
lymphocyte populations independently of the IFNAR/CD69/
S1PR1 axis. In contrast, we show that CD69 is a critical
mediator of selective effector cell retention following TCR-
mediated priming. Collectively, we propose that two distinct
mechanisms sequester lymphocytes in secondary lymphoid
organs: a first pathway, which acts through TCR and CD69 and
affects the capacity of individual cells to leave the organ, and a
second pathway, which is CD69-independent, encompasses the
entire compartment, and likely relies on changes in both the
lymphocyte and lymphoid organ environment.
RESULTS
Hypertrophy of Salmonella-infected PPs results from
reduced lymphocyte egress
Intestinal PPs are secondary lymphoid organs that participate
in homeostatic lymphocyte recirculation, release naive
lymphocytes into efferent lymph in an S1PR1-dependent
manner,19 and become hypertrophic during infection. The
experimental model we used to investigate PP hypertrophy is
an oral infection with an attenuated strain of Salmonella
enterica Serovar Typhimurium (SL1344DaroA). This strain
enters PPs, established infection and spreads to mesenteric
lymph nodes (mLNs), liver, and spleen.33 Seven days after
infection, PPs had visibly enlarged in size and contained on
average 1.5-fold more cells than PPs from non-infected control
mice (Figure 1a). The lymphocyte composition in PPs did not
change substantially during the first week of infection
(Figure 1b), suggesting that PP hypertrophy does not result
from an increase in frequency of a particular subpopulation but
from the accumulation of all major PP cell types. Consistently,
PP lymphocyte populations did not strongly incorporate the
thymidine analog 5-bromo-2-deoxyuridine throughout the
infection period, indicating that cell proliferation did not
substantially contribute to lymphocyte accumulation in
infected PPs (Figure 1c). To address whether lymphocyte
entry into infected PPs was increased and contributed to PP
hypertrophy, we performed short-term adoptive transfer
experiments. Congenically marked lymphocytes were trans-
ferred intravenously to non-infected or infected recipients on
days 1, 3, or 7 of infection. The number of transferred cells in
PPs was determined at 2 or 4 h post transfer. At these early time
points, the number of transferred cellsmonitors entry and is not
affected by egress.34 Entry of transferred cells into infected PPs
was not significantly enhanced in infected compared with non-
infected recipients (Figure 1d), suggesting that changes in
lymphocyte recruitment are not a major contributor to
lymphocyte accumulation in infected PPs.
Besides lymphocyte entry and proliferation, the rate of
lymphocyte egress determines lymphoid organ cellularity. We
therefore addressed whether infection altered lymphocyte
egress from PPs. Lymphocytes leave PPs via lymphatics
leading to mLN. Flow cytometry of mLN-afferent intestinal
lymph showed a large percentage of naive CD62Lþ lympho-
cytes (Figure 2a, b), suggesting that cells originating from PPs
and intestinal follicles account for a substantial proportion of
cells in the intestinal lymph. To measure lymphocyte egress
from PPs during infection, we determined cell numbers in
mLN-afferent lymphatics using two-photon microscopy. Bone
marrow from enhanced green fluorescent protein (EGFP)-
expressing donors was grafted to irradiated recipient mice to
fluorescently mark all hematopoietic cells. Bone marrow
chimeras were infected for 7 days or not infected and the
number or EGFPþ cells in lymphatics was determined. This
approach provided a first indication that egress from infected
PPs was reduced (Figure 2c). To selectively mark PP-derived
cells in the intestinal lymph and other compartments, we
injected fluorescein isothiocyanate (FITC) into PPs
(Figure 2d). FITC injection marked virtually all cells in PPs
(Figure 2e). One day after injection, PPs contained newly
recruited non-labeled cells along with B25% of FITCþ cells
that had remained in PPs since the injection (Figure 2f).
Concomitantly, FITCþ cells were found in mLN, peripheral
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lymph nodes, spleen, and blood 1 day after FITC injection
(Figure 2f). To confirm that these cells originated from PPs,
we orally administered the S1P receptor agonist FTY72035
before FITC injection to block egress from PPs. One day after
injection, the percentage of FITCþ cells in PPs of FTY720-
treated control mice was still 475% and the percentage of
FITCþ cells found in other organs was lower than that in
untreated mice (Figure 2f). These results validate that FITCþ
cells in other organs originate from PPs. To directly monitor
egress from PPs, we isolated mLN-afferent lymph 1 day after
FITC injection. Comparing lymph isolations from non-
infected and days 5–8 infected mice, we observed a significant
reduction in the percentage of FITCþ—that is, PP-derived
cells—among intestinal lymph cells (Figure 2g). These
results provide direct evidence that infection reduces egress
from PPs.
Localized Salmonella infection sequesters lymphocytes in
PPs
To measure the efficiency of lymphocyte egress from infected
PPs, we FITC-injected PPs on different days of Salmonella
infection and analyzed them 1 day later (Figure 3a). Percen-
tages of FITCþ cells in PPs 1 day after FITC injection steadily
increased during the course of infection (Figure 3b). As
lymphocyte entry into infected PPs was not increased during
infection, the percentages of FITCþ cells in PPs provided a
direct measure of the degree of lymphocyte retention. Infection
strongly increased the retention of CD19þ and CD8aþ cells.
This effect was visible when the entire population of CD19þ or
CD8aþ cells was analyzed but was most prominent among
the CD62Lþ naive subpopulations, which account for the
majority of CD19þ and CD8aþ cells in PPs (Supplementary
Figure 1a, b online). Of note, the effect on CD4þ cells was less
pronounced because theCD4þ cell population comprises up to
50%ofCD62L effector/memory cells—for example, follicular
helper T cells—which show high retention rates even in non-
infected mice (see ref. 28 and Supplementary Figure 1a, b).
Nevertheless, progressively increasing percentages of FITCþ
cells among CD19þ and CD8aþ cells suggested that infection
induced lymphocyte retention in PPs and that the degree of
retention was associated with the stage of the infection. On day
8 or day 9 of infection, we furthermore observed that dis-
semination of FITCþ cells into other organs was significantly
reduced compared with early infection time points or non-
infected mice (Figure 3c). These data indicate that all
major recirculating lymphocyte populations are trapped in
infected PPs.
In addition to FITC injection, we used a photoconversion
approach to label all cells in PPs.27,28 To this end, we generated
bone marrow chimeras expressing a histone-fusion variant of
the photoconvertible fluorochrome Dendra2 (H2B-Dendra2),
which changes from green to red emission upon exposure to
ultraviolet/violet light. To photoconvert H2B-Dendra2-expres-
sing lymphocytes in PPs, individual PPs were illuminated with
Figure 1 Lymphocyte composition and turnover during infection-induced Peyer’s patch (PPs) hypertrophy. (a) Cell counts in non-infected
(d0) or Salmonella-infected (d7) PPs. Medianþ inter-quartile range (IQR) of 61 and 89 individual PPs from 10 to 12 mice per group, four independent
experiments. (b) PP cell composition, determined using flow cytometry.Meanþ s.d. of individual PPs from total 45mice, eight independent experiments.
(c) 5-bromo-2-deoxyuridine (BrdU) incorporation into PP cells during infection. Non-infected (d0) or infected (d7) mice were given BrdU in the
drinkingwater for 7 days.Oneof two independent experiments,meanþ s.d. of fourmice per group, PPpools analyzed. (d) Lymphocyte entry into infected
PPs.A total of 107 cellswere transferred tonon-infected or infected congenic recipients.PPswereanalyzed2or 4 h later. IndividualPPs fromnine (d0), six
(d1), or three (d3, d7) mice per group, four independent experiments. Numbers normalized to average number of transferred cells in non-infected PPs.
One-way analysis of variance (ANOVA) with Tukey’s multiple comparison test.
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ultraviolet/violet light for 10 s (Figure 4a). After illumination,
almost all Dendra2-expressing cells in PPs emitted a Dendra2-
Red signal (Figure 4b). Consistent with the FITC-injection
approach, 1 day after photoconversion, percentages of
Dendra2-Red cells had declined to around 25%, whereas
in FTY720-treated mice, percentages remained at B70%
(Figure 4c). We next infected H2B-Dendra2-expressing bone
marrow chimeras with SL1344DaroA. PPs were illuminated on
day 5 of infection and analyzed 1 day later. In accordance with
our observations in FITC-injected PPs, Salmonella infection
increased the percentage ofDendra2-Red cells in PPs 1 day after
photoconversion, compared with PPs from non-infected
mice (Figure 4d). Together, these experiments show that
Salmonella-infected PPs establish an efficient egress blockade
that affects the major lymphocyte populations in PPs.
Systemic administration of TLR ligands abrogates egress
from PPs
Many inflammatory stimuli reduce egress.2,3,9,10,18 We there-
fore tested whether the egress blockade in PPs required active
pathogen replication. To this end, we injected FITC to PPs 2
days after infection with a replication-deficient Salmonella
strain (SL1344DaroADasd). Mice were analyzed 1 day later, at
which time point nomore viable bacteria were detectable in PPs
(data not shown). Lymphocyte retention in SL1344DaroA-
Dasd-infected PPs was lower compared with the same time
point after infection with the replication-competent strain
(SL1344DaroA, Figure 5a). Nevertheless, the proportion of
FITCþ cells in PPs of SL1344DaroADasd-infected mice was
still significantly higher than that in non-infected mice,
suggesting that even in the absence of replication, bacterial
invasion and the presence of bacterial components induced
lymphocyte retention. Similar to the SL1344DaroA infection, 3-
day infection with replication-deficient bacteria did not reduce
dissemination of FITCþ cells from PPs tomLN compared with
non-infected mice (Supplementary Figure 2a). On the basis of
this finding, we tested whether the egress blockade required
ongoing infection. Therefore, we injected mice intraperi-
toneally with 50 mg Escherichia coli lipopolysaccharide (LPS)
shortly after FITC injection and analyzed PPs 1 day later.
Indeed, LPS injection triggered lymphocyte retention in PPs
almost to the same degree as observed after FTY720 treatment
or on late days of Salmonella infection (Figure 5b). A similarly
strong lymphocyte retention was observed when we admini-
stered a Toll-like receptor 7 (TLR7)7/8-activating imidazoqui-
noline compound, R848, po to mice after FITC injection
(Figure 5c). Of note, within a day, these retention effects did not
Figure 2 Infection abrogates lymphocyte egress from Peyer’s patches
(PPs) into intestinal lymph. (a) Lymphocyte composition of intestinal
mesenteric lymph node (mLN)-afferent lymph. Representative
fluorescence-activated cell sorting (FACS) plots gated on DAPI cells.
(b) Intestinal lymph composition, meanþ s.d. of 19 non-infected (d0) and
11 infected (d6–8) mice, seven independent experiments. (c) 2P-
microscopic cell quantification in mLN-afferent lymphatics of non-infected
(d0) or d7-infected mice. Four independent experiments, symbols
represent mice. Mann–Whitney test. (d) Injection of fluorescent dye
fluorescein isothiocyanate (FITC) to label PP cells. (e) Non-injected and
injected PP 2h after injection. Representative FACS plots gated on
DAPI cells. (f) PPs 1 day after FITC injection. FTY720 was given po
before FITC injection to block egress from PPs. Four independent
experiments, total 2–7 mice per group. PP panels: symbols represent
individual PPs. Other organs: symbols represent individual mice.
(g) Quantification of PP-derived intestinal lymph cells. Lymphwas isolated
1 day after FITC injection to PPs. fluorescence-activated cell sorting
(FACS) plots gated on viable cells. Four independent experiments. Two
experiments analyzed CD69wt/ko bone marrow chimeras, further data
fromwhich is shown inFigure 7a. Dots representmice. ‘mLNaff’/’mLNeff’,
mLN-afferent/efferent lymph. Mann–Whitney test.
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induce apparent PP hypertrophy (data not shown) nor did they
strongly reduce the spread of FITCþ cells from PPs to other
lymph nodes (Supplementary Figure 2b). Thus, ongoing
infection or systemic inflammatory stimuli both induce
lymphocyte retention and abrogate egress from PPs.
Lymphocyte retention in infected PPs is independent of
IFNAR, TNFR1, and CD69
Next, we sought to elucidate the mechanism of lymphocyte
retention in Salmonella-infected PPs. To test whether the
IFNAR/CD69/S1PR1 axis was involved, we first addressed
whether IFNAR was required on lymphocytes for their
retention. To this end, we grafted an equal mix of
CD45.1þ wild-type (wt) and CD45.2þ IFNAR / (ko) bone
marrow to lethally irradiated CD45.1þ wt recipients. These
‘‘IFNARwt/ko chimeras’’ were infected with Salmonella for 5–6
days, PPs were FITC-injected, and analyzed 1 day later
(Figure 6a). Both IFNAR-proficient and IFNAR-deficient
lymphocytes were efficiently retained in PPs of IFNARwt/ko
chimeras (Figure 6b), indicating that IFNAR is not required on
lymphocytes for their retention in infected PPs.
Besides IFNa/b, TNF-a has been suggested to upregulate
CD69 and abrogate lymphocyte egress.20We therefore infected
TNFR1wt/ko chimeras with Salmonella, FITC-injected PPs on
day 6 of infection, and analyzed them 1 day later. Both TNFR1-
proficient and TNFR1-deficient lymphocytes were efficiently
retained in PPs, suggesting that infection-induced retention
does not require TNFR1 on lymphocytes (Figure 6c). Similarly,
lymphocyte retention in response to LPS was independent of
TNFR1 on lymphocytes (data not shown).
Different triggers blocking egress are thought to converge in
the CD69-dependent pathway. Onemight therefore expect that
stimuli other than IFNa/b or TNF-a could trigger CD69/
S1PR1-mediated retention of recirculating lymphocytes in
infected PPs. Of note, naive lymphocytes express low levels of
CD69 and expression of CD69 on naive lymphocytes was
Figure 3 Salmonella infection causes retention of the major lymphocyte populations in Peyer’s patches (PPs). (a) PPs 1 day after fluorescein
isothiocyanate (FITC) injection. Representative fluorescence-activated cell sorting (FACS) plots gated on DAPI cells. (b) Lymphocyte retention in
hypertrophic PPs. Non-infected or Salmonella-infected PPs were FITC-injected and analyzed 1 day later. Eight independent experiments
comparing non-infectedmice (total 18) to d3 (4mice), d5 (3), d6 (1), d8 (11), or d9 (3) infectedmice. The indicated ‘‘day of infection’’ is the day of analysis.
Symbols represent individual PPs. %FITCþ cells was determined among CD19þ /CD4þ /CD8aþ PP subpopulations. Meanþ s.d. of individual PPs.
Kruskal–Wallis with Dunn’s multiple comparison test. (c) Dissemination of FITC-labeled, PP-derived cells into mesenteric lymph node (mLN),
peripheral lymph nodes, and blood. Meanþ s.d. of individual mice, see (b) for number of mice and experiments. Kruskal–Wallis with Dunn’s multiple
comparison test.
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not altered in infected compared with non-infected PPs
(Supplementary Figure 3a, b), suggesting that naive lym-
phocyte retention was not because of elevated expression of
CD69. To test whether CD69 was required on lymphocytes for
their retention in infected PPs, we examined CD69wt/ko
chimeras (Figure 7a). In non-infected CD69wt/ko chimeras,
percentages of FITCþ cells among CD69-deficient PP cells
were lower than those among CD69-proficient cells, suggesting
that CD69-deficient lymphocytes have a lower dwell time in
PPs than wt lymphocytes. Nevertheless, in infected CD69wt/ko
chimeras, both CD69-proficient and CD69-deficient PP cells
displayed increased percentages of FITCþ cells compared with
non-infected chimeras, suggesting that both populations were
efficiently retained. As observed previously, retention affected
mainly CD19þ and CD8aþ lymphocytes. Retention values
increased by at least the same factor for CD69-deficient and
CD69-proficient lymphocytes, suggesting that the infection-
induced retention mechanism overcomes the defect which
CD69-deficiency imposes on homeostatic recirculation. In the
same PP, there was a significant correlation between retention
of CD69wt and CD69ko subpopulations, suggesting that the
lymphocyte egress blockade affected both populations with the
same efficiency. These results indicate that CD69 is not
required on lymphocytes for their retention in PPs during
Salmonella infection and that the infection-induced egress
blockade relies on CD69-independent mechanisms.
Infection-induced shutdown requires several days to estab-
lish and could rely on complex changes in lymphocytes and
lymphoid organ environment. In comparison, LPS-induced
retention was relatively fast. We therefore also tested whether
LPS-induced lymphocyte retention required CD69 expression.
To this end, FITC was injected to PPs of CD69wt/ko chimeras
and 50 mg LPS were intraperitoneally injected shortly after
surgery. Analysis 1 day later showed that LPS-induced reten-
tion of CD69-deficient and CD69-proficient cells was equally
efficient (Figure 7b). Consistently, we observed that adoptively
transferred CD69-deficient CD19þ cells were efficiently
retained in PPs after LPS injection (data not shown). Therefore,
we propose that even fast ‘‘shutdown’’ can occur independently
of CD69.
Two distinctmechanisms promote lymphocyte retention in
PPs
To reconcile our findings with a proposed role for IFNa/b/
CD69/S1PR1, we hypothesized that two distinctmechanisms of
lymphocyte retention must exist, which differ in their
requirement of CD69. CD69 has been suggested to retain
lymphocytes during the first hours of lymphocyte activation
before other mechanisms, such as transcriptional regulation of
S1P receptors, are initiated.24 We therefore measured S1PR1
transcript levels in CD19þCD62Lþ cells sorted from PPs.
However, we did not observe a consistent reduction in S1PR1
transcript levels in cells from infected PPs compared with cells
from non-infected PPs (Figure 8a). Recently, CXCR4 has been
reported to promote B-cell egress from PPs.28 We therefore
measured CXCR4 surface expression on PP cells from non-
treated, LPS-treated, and day 7-infected mice. CXCR4 expres-
sion was almost exclusively found on CD19þ cells. However,
expression was unaltered in lymphocytes from infected PPs
compared with non-infected PPs (Figure 8b). These results
suggest that infection does not retain lymphocytes through
direct regulation of the lymphocyte egress factors S1PR1 and
CXCR4.
To understand which circumstances determine the mode of
lymphocyte retention, we next sought to identify stimuli that
sequester lymphocytes in a CD69-dependent manner. TCR-
mediated antigen recognition efficiently induces CD69 expres-
sion.We therefore tested whether upon priming, CD4þ T cells
would require CD69 for their retention. To this end, CD69-
proficient or CD69-deficient transgenic ovalbumin (OVA)-
specific OTII cells were labeled with cell proliferation dye and
adoptively transferred into congenic wt recipients. OTII cells
were activated by oral administration of 50mg OVA, in the
absence of adjuvant. PPs were FITC-injected 2 days later and
analyzed 1 day after. Interestingly, althoughOTII cells in PPs of
Figure 4 Photoconversion reveals infection-induced lymphocyte
retention. (a) Illumination of Peyer’s patches (PPs) to photoconvert
Dendra2-expressing cells. PPs of bone marrow chimeras expressing the
red-to-green photoconvertible fluorochrome Dendra2 were illuminated
with ultraviolet (UV) light of 370–410 nm. (b) PP immediately after
illumination. All Dendra2-expressing cells emit a Dendra2-Red signal.
(c) FTY720 was given po 4 h after the photoconversion surgery to block
egress from PPs. PPs were illuminated and analyzed 1 day later. Four
control and two FTY720-treated mice. Symbols represent a pool of one to
two PPs. (d) Infection-induced lymphocyte retention shown by
photoconversion of Dendra2. Dendra2 bone marrow chimeras were not
infected (d0) or infected for 5 days (d5). PPs were illuminated to convert
Dendra2-Green to Dendra2-Red. Retention of Dendra2-Red cells in PPs
was analyzed 1 day later. Two independent experiments, six non-infected
and four infectedmice; symbols represent a pool of oneor twoPPs.Mann–
Whitney test.
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OVA-fed mice were proliferating, the percentage of FITCþ
cells among all PPs cells had not increased in OVA-fed
compared with control mice (Figure 8c). This suggests that
antigen-specific activation of T cells per se does not necessarily
shut down egress of all lymphocytes in the compartment. In
contrast, percentages of FITCþ cells among proliferating
CD69þ /þOTII cells had increased to around 70%, indicating
that activated OTII cells were selectively retained in PPs.
Strikingly, percentages of FITCþ cells among CD69 /OTII
cells were significantly lower than those amongCD69þ /þOTII
cells, suggesting that the retention of activated OTII cells was
dependent on CD69. These results suggest that CD69-
dependent retention mechanisms require specific activation
of the lymphocyte and act via a lymphocyte-intrinsic
mechanism, whereas other cells in the same compartment
remain unaffected.
In contrast to this selective retention mode, infected PP
shutdown retained all lymphocytes in the organ.We next tested
whether this process required antigen recognition by the
affected lymphocytes. To this end, we investigated whether
non-activated OTII cells would be retained by Salmonella-
induced shutdown. OTII cells were adoptively transferred to
congenic recipients. One day later, mice were infected with
Salmonella. PPs were FITC-injected on day 4 or 5 of infection
and analyzed 1 day later. CD4þ OTII cell retention in infected
PPs increased by about the same factor as that of transferred
CD19þ cells and endogenous PP cells (Figure 8d), suggesting
that CD4þ T cell retention during Salmonella infection does
not require antigen recognition by the lymphocyte.
Altogether, these findings show that during infection, PPs
establish a compartment-wide egress blockade that affects
the major lymphocyte subsets and does not require CD69
expression on lymphocytes. In contrast, CD69 is critical to
retain activated lymphocytes in PPs for several divisions by a
mechanism that does not affect other cells in the compartment.
DISCUSSION
Lymphoid organ hypertrophy is a fundamental component of
the immune response to localized infection14,15,17 and diverse
inflammatory triggers.1–10 In contrast, the IFNAR/CD69/
S1PR1 axis has remained the only lymphocyte-intrinsic
mechanism described to date that links inflammatory stimuli
and lymphocyte egress.20 In this study, we describe the
requirements for lymphocyte egress in a model of localized,
infection-induced lymphoid organ hypertrophy and extend the
current hypothesis that the IFNAR/CD69/S1PR1 axis mediates
lymphoid organ shutdown during this type of immune
response.11,12,20,24,25
Using in vivo photoconversion as well as fluorescent labeling
of PP cells combined with analysis of the intestinal lymph, we
directly monitored lymphocyte egress from intestinal PPs
during infection. Our findings provide direct evidence that PP
Figure 5 Lymphocyte retention in Peyer’s patches (PPs) after infection with replication-deficient Salmonella or systemic Toll-like receptor (TLR)
stimulation. (a) Mice were not infected, infected for 2 days with SL1344DaroA, or infected for 2 days with replication-deficient strain SL1344DaroADasd.
PPs were fluorescein isothiocyanate (FITC)-injected and analyzed 1 day later (d0, d3, d3Dasd, respectively). Two independent experiments,
total five to six mice per group. Dots represent individual PPs. One-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test.
(b) Mice were given 50mg LPS intraperitoneally after FITC-injection. PPs were analyzed 1 day later. Two independent experiments, total two to
three mice per group. Dots represent individual PPs. (c) Mice were given 10 mg R848 po after FITC injection. PPs were analyzed 1 day later. Three
independent experiments, five to six mice per group. Symbols represent individual PPs. Note that data from two of the control mice are identical to data
shown in Figure 2f because control mice, R848-treated mice, and FTY720-treated mice were analyzed in the same experiments.
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hypertrophy is the result of a compartment-wide egress
blockade. With progressive infection, the efficiency of lympho-
cyte egress decreased. This egress blockade and resulting
lymphocyte retention were the major cause of PP hypertrophy.
In contrast, enhanced lymphocyte recruitment and prolifera-
tion did not decisively contribute to PP enlargement. Many
studies have suggested that increased recruitment of
lymphocytes is the major cause of lymphoid organ hyper-
trophy.4–6,8,14,15,36,37 Although multiple inflammatory stimuli
are known to temporarily abrogate egress,2,3,9,10,18 and such
observations have been referenced in the context of lymphoid
organ hypertrophy, egress from secondary lymphoid organs
has hardly been investigated during local infection because
of the inavailability of suitable methods to measure egress. In
fact, increased accumulation of adoptively transferred cells
during infection, interpreted as an increase in entry, might also
mirror a block in egress.8,14 Using direct readouts of
lymphocyte egress and retention, we show that local infection
causes a sustained egress blockade that mediates lymphoid
organ hypertrophy.
Figure 6 Lymphocyte retention in Salmonella-infected Peyer’s patches (PPs) is independent of type I interferon receptor (IFNAR) and tumor
necrosis factor (TNF)-a receptor 1. (a) Experimental setup to investigate effect of IFNAR deficiency on lymphocyte retention in PPs. Irradiated recipients
were given bone marrow from CD45.1þ wild-type (wt) and CD45.2þ IFNAR / donor mice. Thus, generated mixed IFNARwt/ko chimeric mice were
infected with Salmonella strain SL1344DaroA. PPs were fluorescein isothiocyanate (FITC) injected and analyzed 1 day after injection. Fluorescence-
activated cell sorting (FACS) plots show the gating strategy for analysis. The left plot is gated on viable PP cells. Corresponding setups were
used to investigate the effects of TNFR1andCD69deficiency. (b) Lymphocyte retention inPPsof infected IFNARwt/ko chimeras.PPcellswere subgated
on IFNARwt and IFNARko cells andpercentage of FITCþ cells was determined. IFNARwt and IFNARko cellswere further subgated onCD19/CD4/CD8a
and analyzed for retention. Two independent experiments, total six mice per group. Mice were analyzed on day 6 or 7 of infection (‘inf’). Symbols
represent individual PPs. (c) Lymphocyte retention in PPs of infected mixed TNFR1wt/ko chimeras was investigated as described in (a) and (b). Two
independent experiments, total seven to eight mice per group. Dots represent individual PPs.
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Importantly, lymphocyte retention was not restricted to
activated effector cells. Instead, retention affected most
prominently the CD62L-expressing, naive recirculating lym-
phocyte populations. This process did not require antigen-
specific activation, engagement of IFNAR or TNFR1, or CD69.
Infection-induced lymphoid organ shutdown can thus occur
independently of the CD69-dependent pathway and does not
rely on sequestration of every individual lymphocyte following
activation through lymphocyte-expressed IFNAR, TNFR1, or
CD69. Instead, infection-induced shutdown is global—that is,
it encompasses all naive, recirculating lymphocyte populations,
prolongs their retention, and inhibits their exit into the lymph.
In contrast to infection-induced shutdown, retention of
activated CD4þ T cells in PPs was selective to this population
andwas dependent onCD69.Our data thus show thatCD69 is a
critical mediator of TCR-triggered lymphocyte retention and
answer the open question whether CD69 can function
downstream of TCR to abrogate egress.24 CD69 is rapidly
upregulated on newly activated CD4þ T cells, presumably
causing the loss of surface S1PR1.25 S1PR1 is transcriptionally
downregulated in activated CD4þ T cells19 until surface
expression starts to gradually recover to the point where T cells
are thought to gain capacity to leave the lymphoid organ.19,38 In
accordance with this model, we observed that activated T cells
were retained in PPs for several divisions in a CD69-dependent
manner. The role of CD69 in TCR-mediated retention can
possibly explain the effect of CD69 deficiency on recirculation
kinetics of lymphocytes in the steady state. Retention rates of
CD69-deficient CD19þ and CD8aþ lymphocytes in PPs were
consistently lower than those of the corresponding wt
lymphocytes in the same organ. These results are in accordance
with other reports proposing antigen-encounter events to be an
Figure 7 Lymphocyte retention afterSalmonella infection or systemic LPS administration is independent of CD69. (a) Lymphocyte retention in Peyer’s
patches (PPs) of Salmonella-infected mixed CD69wt/ko chimeras. Mice were analyzed on days 5–7 of infection, 1 day after FITC-injection,
respectively (‘inf’). Four independent experiments, total six to seven mice per group. Symbols represent individual PPs. To calculate fold increase in
retention, the average percentages of fluorescein isothiocyanate positive (FITCþ ) cells among the indicated populations in infected PP were divided by
those in non-infected PP. Dashed line indicates fold increase of 1. Meanþ s.d. of three experiments. Correlation of retention values (%FITCþ of
population) between indicated CD69wt and CD69ko populations in the same PP. r indicates Spearman’s correlation coefficient. (b) Lymphocyte
retention in PPs of LPS-treated CD69wt/ko chimeras. FITC was injected to PPs, 50 mg LPS were given intraperitoneally, and PPs were analyzed 1 day
later. Viable PPs cells were subgated on CD69wt and CD69ko cells. CD69wt and CD69ko cells were further subgated on CD19/CD4/CD8a. One
experiment, two mice per group. Symbols represent individual PPs.
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important factor controlling lymphocyte dwell time in
lymphoid organs.39–41 CD4þ T cell transit through lymph
nodes is accelerated in the absence of MHCII.39 Furthermore,
recognition of self-antigen as well as microbiota have been
suggested to sustain CD69 expression and affect lymphoid
organ transit times.40,41 On the basis of these reports, it appears
conceivable that CD69 deficiency should reduce lymphocyte
dwell time in the lymphoid organs.
Our findings suggest that the mode of lymphocyte retention
observed in Salmonella-infected PPs and in response to
systemic TLR stimulation is distinct from the previously
described CD69-mediated pathway.20 In Salmonella-infected
PPs, lymphocytes were retained without specific activation
through one of the previously named lymphocyte-expressed
receptors. One might speculate that this mode of retention
relies on changes in the lymphoid organ environment, like
alterations in the availability of S1P12,32,42,43 or effects on the
barrier function of lymphatic endothelium.43–45 A long-
standing debate concerns the distinction between such
compartment-wide effects and lymphocyte-intrinsic seques-
tration mechanisms. Seminal findings on lymphocyte egress
arose from investigation of the immunosuppressive effects of
FTY720. In its phosphorylated form, FTY720 engages S1P
receptors and abrogates lymphocyte egress.35 S1P receptors are
present on lymphocytes as well as on non-hematopoietic cells,
such as on vascular and lymphatic endothelium. Controversy
still surrounds the question whether FTY720 blocks lympho-
cyte egress mainly through ‘‘functional antagonism’’—that is,
internalization and inactivation of S1PR1 on lympho-
cytes19,46,47 or rather through agonism on lymphatic endothe-
lial S1PR1, whichmodulates portals in the egress barrier.35,43–45
Broadly speaking, this discussion concerns whether major
changes in lymphocyte egress are controlled on the level of the
lymphocyte or the lymphoid compartment.24,43,48 Our findings
might offer an explanation to reconcile these conflicting
concepts. We propose that at least two distinct lymphocyte
sequestration pathways exist, which can be individually
triggered in an uncoupled manner. Antigen-specific priming
selectively trapped activated T cells in PPs, demonstrating that
TCR-mediated CD69 activation abrogates lymphocyte egress
through a lymphocyte-intrinsic retention mechanism. In
contrast, infection-induced shutdown affected all lymphocyte
populations in the compartment independently of their
activation status or CD69 expression. Inflammation-induced
changes in the compartment could account for this effect. Still,
Figure 8 CD69-dependent and -independent lymphocyte retention
mechanisms. (a) Quantitative RT-PCR analysis of sphingosine-1-
phosphate receptor 1 (S1PR1) expression in fluorescence-activated cell
sorting (FACS)-sorted CD19þCD62Lþ cells from non-infected and day
7-infected Peyer’s patches (PPs). A total of 13 (d0) and 12 (d7) samples
generated in eight independent sorts. For one sample, PPs were pooled
from one to two mice. Meanþ s.d. of samples. (b) CXCR4 expression on
CD19þ cells in PPs of non-infected (ctrl), LPS-treated (LPS), and day 7-
infected (d7) mice, determined using flow cytometry. Two independent
experiments, total four to six mice per group. Symbols represent PP pools
from individual mice. (c) Selective retention of activated CD4þ T cells.
CD69wtOTII or CD69 /OTII cells labeled with cell proliferation dye were
transferred to congenic recipients. Fifty microgram OVA were given po,
PPs were fluorescein isothiocyanate (FITC)-injected on day 3 and
analyzed on day 4. Symbols represent individual PPs. One-way analysis
of variance (ANOVA), Tukey post test. FACS plot from CD69wtOTII
transfer shows transferred CD4þ cells. Transferred CD4þ cells were
subgated on division cycles. Meanþ s.d. of individual PPs. Two-way
ANOVA, Bonferroni post test comparing genotypes. Four experiments
with total 4 (noOVA), 11 (CD69wtOTIIþOVA), 8 (CD69 /OTIIþOVA),
and three mice per group (LPS). (d) Retention of non-activated OTII cells.
OTII cells were transferred to congenic recipients. Mice were infected or
not infected and analyzed on days 5–6, 1 day after FITC injection. Left
FACS plot is gated on viable PP cells, subsequent plots gated on indicated
subpopulations. Two experiments, total four (d0) and six (d5–6) mice.
Symbols represent individual PPs. Mann–Whitney test. Fold retention
infected/non-infected PPs. Meanþ s.d. of experiments.
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both mechanisms could include transcriptional regulation of
the egress machinery.24 Whether infection-induced shutdown
interferes with S1PR1-mediated egress is open. Egress fromPPs
is S1PR1-dependent19 and FTY720 blocks PP egress of
plasmablasts49 and naive lymphocytes (see ref. 28 and our
data); therefore, it remains possible that the infection-induced
egress blockade targets this critical pathway.
The two distinct retentionmechanisms might serve different
purposes. Lymphoid organ shutdown is commonly suggested
to serve the efficient induction of adaptive immune responses
by increasing the frequency of pathogen-specific naive
lymphocytes and fostering lymphocyte–antigen encoun-
ters.4,8,11–13 This explanation entails that lymphoid organ
shutdown could subside after successful lymphocyte priming.
Conversely, we observed that the egress blockade continued
and intensified for 9 days after infection. Moreover, our data
suggest that the CD69-dependent, lymphocyte-intrinsic
sequestration mechanism is sufficient to initiate the retention
of activated T cells. Thus, the infection-induced and compart-
ment-wide egress blockade might be required for reasons other
than to foster lymphocyte–antigen encounters.4,11,12 One
option might be that the two mechanisms are hierarchically
organized, and infection-induced shutdown allows prolonged
retention of activated effector cells compared with activation
under non-inflammatory conditions. This could favor matura-
tion of effector cells24 or the generation of specific memory. If
the infection-induced egress blockade relies on physical
reinforcement of the egress barrier, another purpose might
be to reduce dissemination of pathogens or toxins, avert cell-
bound pathogen spread,50 and provide additional protection
from systemic infection.
METHODS
Mice. Wt (C57BL/6N, Charles River, Sulzfeld), CD45.1þ mice
(B6.SJL-Ptprca Pepcb/BoyJ), TNFR1-deficient mice (B6.129-
Tnfrsf1atm1Mak/J, The Jackson Laboratory, Bar Harbor, ME), Actin-
EGFP mice (C57BL/6-Tg(CAG-EGFP)1Osb/J), and OTII-Ly5.1 mice
(B6.Cg-Tg(TcraTcrb)425Cbn/JB6.SJL-Ptprca Pepcb/BoyJ) were
bred and reared in individually ventilated cages at the Central Animal
Facility of Hannover Medical School. IFNAR-deficient mice
(B6.129SV/EV-IFNAR1tm1Aguet/F20) were bred at Twincore,
Hannover. CD69-deficient mice (B6.129P2-Cd69tm1Naka) and
CD69-deficient OTII mice were bred at the Animal Research Centre
(Tierforschungszentrum) of the University Clinic Ulm. All mouse
experiments were performed in accordance with the German Law for
the Protection of Animal Welfare (Tierschutzgesetz). Experiments
were approved by the Lower saxony state office for consumer pro-
tection and food safety (Landesamt fu¨r Verbraucherschutz und
Lebensmittelsicherheit, LAVES).
Reagents. FITC (F2502, Sigma-Aldrich, St Louis, MO) was freshly
diluted at 1mg/ml in sterile phosphate-buffered saline before use. 5-
Bromo-20-deoxyuridine (B5002, Sigma-Aldrich) was given in the
drinking water at a concentration of 0.8mg/ml. On the first day of 5-
bromo-2-deoxyuridine administration, mice were additionally given
3mg 5-bromo-2-deoxyuridine intraperitoneally. FTY720 (Fingolimod,
F-4633, LC laboratories, Woburn, MA) was given po at a dose of 25mg
permouse. Lipopolysaccharide fromE. coli (LPS, L4005, Sigma-Aldrich)
was injected intraperitoneally at a dose of 50mg per mouse. Imida-
zoquinoline compound R848 (tlrl-r848, Invivogen, San Diego, CA) was
given po at a dose of 10mg per mouse. Albumin from chicken egg white
(Ova grade III, A5378, Sigma-Aldrich) was diluted in phosphate-
buffered saline and 50mg in 200ml were given po to every mouse.
Cell isolation, cell transfers, and flow cytometry were performed as
described in Supplementary Methods.
Bacterial infection. S. enterica Serovar Typhimurium strains
SL1344DaroA and SL1344DaroADasd were grown in LBmediumwith
Streptomycin or LB/Streptomycin/Kanamycin supplemented with
50 mg/ml diaminopimelic acid (DAP, D1377, Sigma), respectively.
Bacteria were harvested for infection during exponential growth
phase and washed with LB/antibiotics and 3% NaHCO3. A total of
5–10 109 bacteria were given po in LB/antibiotics/NaHCO3. With
the exception of experiments shown in Figure 5a, all experiments
were performed with the replication-competent Salmonella strain
SL1344DaroA.
GenerationofH2B-Dendra2-expressingbonemarrowchimeras. To
generate the H2B-Dendra2 expression construct (MigH2BD2),
Dendra2 from the pDendra2-N plasmid (Evrogen, Moscow, Russia)
and IRES2-H2B from the pBOS-IRES2-H2BEGFP plasmid (kindly
provided by Immo Prinz, Hannover Medical School) were cloned into
the MigR1 plasmid51 in the place of IRES-EGFP through stepwise
NcoI/ClaI and AgeI/XhoI digests. To generate H2B-Dendra2-con-
taining virus, the resulting MigH2BD2 together with pCL-Eco was
transfected into HEK-293T cells. Virus-containing supernatant was
harvested on the three following days. To enrich bone marrow
precursor cells, bone marrow was incubated with rat IgG antibodies to
CD11b, CD8b, CD49b, CD4, Gr-1, B220, CD11c, and CD19. Cells
were then incubated with sheep anti-rat IgG Dynabeads (Invitrogen),
and the labeled cell populations were depleted using magnetic
separation. Enriched bone marrow precursor cells were cultured with
IL-7, IL-6, SCF, and Flt3L for 4 days and infected with H2B-Dendra2-
expressing virus on days 2 and 4 using spin infection. On day 5, cells
were harvested and 106 cells were transferred intraventrally to
irradiated recipients.
Bonemarrow chimeras. Recipient mice were irradiated at 10Gy. For
mixed chimeras, donor bone marrow from WT and IFNAR/TNFR1/
CD69-deficient mice was mixed at a 1:1 ratio. For mixed chimeras
and EGFP chimeras, 107 cells were transferred intraventrally via the
tail vein. For Dendra2-H2B chimeras, Dendra2-H2B-transduced
enriched bone marrow precursor cells were harvested and 106 cells
were transferred intraventrally All bone marrow recipients were given
antibiotics in the drinking water for 2 weeks after irradiation
(Cotrimoxazol, Ratiopharm, Ulm, Germany). Mice were analyzed
after 6 weeks or later.
Two-photonmicroscopy of lymphatics. Two-photon microscopy of
lymphatics was performed as described.52 Briefly, 200 ml olive oil were
given po 1 h before analysis and TRITC-labeled dextrane was injected
intraventrally 20min before analysis. At the time point of analysis,
mice were anaesthetized, lymphatics were ligated close to the mLN,
and themice were killed by cervical dislocation. An explant containing
a piece of the small intestine, the mLN, and the connecting lymph and
blood vessel bundles was glued into a petri dish and analyzed under the
microscope.
FITC injection and photoconversion surgery. Mice were anaes-
thetized using ketamine and xylazine. The peritoneal cavity was
opened through a small midline incision into the skin and the
abdominal wall. The small intestinewas exposed and FITC (1mg/ml in
phosphate-buffered saline) was injected to the first five PPs starting
from the cecum. Every follicle was injected individually, using a fine
glass capillary mounted to the needle holder of a micro-injector
(Harvard Apparatus). For photoconversion, PPs were exposed for 10 s
at a low intensity to ultraviolet/Violet light of wavelength 370–410 nm
from a BlueWave 75 light curing system (Dymax, CT) equipped
with a 390/40 band pass filter. During illumination, tissue surrounding
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the PPs was covered with aluminum foil to avoid unwanted
photoconversion. Four to five PPs were photoconverted per mouse
and their position was mapped for analysis.
Real-time PCR. Quantitative real-time PCR of S1PR1 expression on
complementary DNA from fluorescence-activated cell sorting-sorted
CD19þCD62LþDAPI cells was carried out as described in
Supplementary Methods.
Statistics. Statistical analysis was performed using Graph Pad Prism.
Unless indicated otherwise, plots show data pooled from several
independent experiments. Number of mice, PPs, and independent
experiments are given in the Figure legends. In dotplots, horizontal
lines indicate the mean and one dot represents an individual PP or an
individual mouse, as indicated. Bar graphs indicate meanþ s.d.
Statistical differences between two groups were determined using the
Mann–Whitney test. Three ormore groups were compared using one-
way analysis of variance or Kruskal–Wallis tests. If the overall P-value
was o0.05, multiple comparison tests were performed. P-values for
pairwise comparisons are indicated as follows: *Po0.05, **Po0.01,
***Po0.001, nonsignificant (n.s.) P40.05.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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